NAPROXEN AND ESOMEPRAZOLE MAGNESIUM (naproxen and esomeprazole magnesium) by Gen Pharmaceuticals is cyclooxygenase inhibitors [moa]. Approved for adolescent patients 12 years of age, older weighing at least 38 kg, requiring naproxen for symptomatic relief of arthritis and 3 more indications. First approved in 2023.
Drug data last refreshed 18h ago
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug
Worked on NAPROXEN AND ESOMEPRAZOLE MAGNESIUM at Gen Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.